Glen Eagle Advisors, LLC Boston Scientific Corp Transaction History
Glen Eagle Advisors, LLC
- $546 Billion
- Q2 2024
A detailed history of Glen Eagle Advisors, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Glen Eagle Advisors, LLC holds 847 shares of BSX stock, worth $73,587. This represents 0.01% of its overall portfolio holdings.
Number of Shares
847Holding current value
$73,587% of portfolio
0.01%Shares
12 transactions
Others Institutions Holding BSX
# of Institutions
1,484Shares Held
1.21BCall Options Held
8.09MPut Options Held
8.42M-
Vanguard Group Inc Valley Forge, PA130MShares$11.3 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY126MShares$11 Billion0.22% of portfolio
-
State Street Corp Boston, MA61.5MShares$5.34 Billion0.21% of portfolio
-
Primecap Management CO Pasadena, CA38MShares$3.3 Billion2.15% of portfolio
-
Wellington Management Group LLP Boston, MA32.1MShares$2.79 Billion0.45% of portfolio
About BOSTON SCIENTIFIC CORP
- Ticker BSX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,431,609,984
- Market Cap $124B
- Description
- Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...